Pulmatrix, Inc. (PULM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
26 Pages - GLDATA55943
$250.00

Summary

Pulmatrix, Inc. (Pulmatrix), formerly known as Ruthigen, Inc. is a biotechnology company that discovers and develops inhaled therapies for prevention and treatment of respiratory diseases. Its product pipeline includes PUR1900, PUR1500 and PUR0200. The company uses iSPERSE platform, a proprietary, dry powder technology developed, patented and validated, used in the treatment of serious pulmonary diseases. Its iSPERSE can be applied to therapeutic compounds from small molecules including iCALM therapies through proteins and antibodies. Pulmatrix’s iSPERSE facilitates delivery of peptides, antibodies and nucleic acids across a range of drug loads. The company offers products for treatment of chronic obstructive pulmonary disease, cystic fibrosis and asthma. Pulmatrix is headquartered in Lexington, Massachusetts, the US.

Pulmatrix, Inc. (PULM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Pulmatrix, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Pulmatrix Raises US$6.5 Million In Extended Series B1 Financing 10
Pulmatrix Secures US$14 Million In Series B1 Venture Financing 11
Partnerships 13
Capsugel Enters into Agreement with Pulmatrix 13
Pulmatrix Enters into Co-Development Agreement with Mylan 14
Quotient Clinical Enters Into Agreement With Pulmatrix For PUR0200 15
Pulmatrix Enters Into Co-Development Agreement With Cystic Fibrosis Foundation Therapeutics 16
Merger 18
Ruthigen Merges with Pulmatrix 18
Equity Offering 19
Pulmatrix Raises USD10 Million in Private Placement of Shares and Warrants 19
Pulmatrix Raises USD0.6 Million in Private Placement of Shares 21
Pulmatrix Raises USD0.9 Million in Private Placement of Shares 22
Pulmatrix, Inc. - Key Competitors 23
Key Employees 24
Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Key Facts, 2015 1
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Pulmatrix, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Pulmatrix, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Pulmatrix Raises US$6.5 Million In Extended Series B1 Financing 10
Pulmatrix Secures US$14 Million In Series B1 Venture Financing 11
Capsugel Enters into Agreement with Pulmatrix 13
Pulmatrix Enters into Co-Development Agreement with Mylan 14
Quotient Clinical Enters Into Agreement With Pulmatrix For PUR0200 15
Pulmatrix Enters Into Co-Development Agreement With Cystic Fibrosis Foundation Therapeutics 16
Ruthigen Merges with Pulmatrix 18
Pulmatrix Raises USD10 Million in Private Placement of Shares and Warrants 19
Pulmatrix Raises USD0.6 Million in Private Placement of Shares 21
Pulmatrix Raises USD0.9 Million in Private Placement of Shares 22
Pulmatrix, Inc., Key Competitors 23
Pulmatrix, Inc., Key Employees 24

List of Figures
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Pulmatrix, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838